[Elsevier] [Supplementary]Atrasentan in patients with IgA nephropathy (ALIGN): final 2﹞5-year results from a randomised, double-blind, placebo-controlled, phase 3 trial |
|
This post will be closed automatically in 2026-06-19 16:42
Best Answer
1 hour(s) ago
|
| |
post
reply
points
5880
10
Unraveling the genomic and metabolic mechanisms of pyrene and phenanthrene degradation by Mycolicibacterium sp. SCSIO 43805: A high-Efficiency bacterium isolated from seagrass sediment
10
Complete genome of Mycolicibacterium phocaicum RL-HY01, a PAEs-degrading marine bacterial strain isolated from Zhanjiang Bay, China
10
Blue biotechnology for aquaculture: A computational approach for identifying marine macroalgae metabolites as potential therapeutics against spring viremia of carp virus
10
Effect of aliovalent substitution in the band structure engineered Ca2+-doped LaFeO3 nanoparticles for visible light-induced photocatalytic studies
10
Gas-phase exfoliation of montmorillonite nanosheets via supercritical fluid: Synthesis and evaluation of Ga(ｋ) adsorption properties
